News and Events

RNA analysis of tape strips can reduce removal of benign lesions

18 June 2023

The objective of this recent study was to further develop the technique of using tape strip derived ribonucleic acid (RNA) to distinguish cutaneous malignant melanoma (CMM) from nevi and validate if RNA profiles can rule out CMM in clinically suspicious lesions with 100% sensitivity. The study concludes that the technique can reduce removal of benign lesions by one-third without overlooking any CMMs.

Review: benefits and harms of routine skin cancer screening in asymptomatic screening populations aged ≥15 years

22 May 2023

According to this recent study there is a clear association between earlier stage at skin cancer detection and decreased mortality risk. Results suggest no melanoma mortality benefit associated with skin cancer screening in adolescents or adults in regions with implemented routine screening compared to regions without routine screening. Results suggest no association between routine clinician skin examination and earlier stage at melanoma detection. There appears to be little direct evidence on harms of screening.

No significant deterioration in health-related quality of life in patients with melanoma brain metastases treated with immunotherapy

8 May 2023

According to this recent study, melanoma brain metastasis patients treated with either ipilimumab–nivolumab or nivolumab did not report a significant deterioration in health-related quality of life within 18 weeks of treatment initiation, providing support for the use of these immunotherapies as first-line treatment for melanoma brain metastases.